comparemela.com

Latest Breaking News On - Dongwoon anatech - Page 2 : comparemela.com

Haptics market 2023-2027: A descriptive analysis of parent market, five forces model, market dynamics, and segmentation

/PRNewswire/ According to Technavio, the global haptics market size is expected to grow by USD 7,523.18 million from 2022 to 2027. The market is estimated.

China
Japan
United-states
India
South-korea
United-kingdom
Texas
America
Jesse-maida
Synaptics-inc
Technavio-research
D-systems-corp

The Global Haptics Market is expected to grow by $7,523.18

Global Haptics Market 2023-2027 The analyst has been monitoring the haptics market and it is poised to grow by $7,523. 18 mn during 2023-2027, accelerating.

New-york
United-states
Texas
America
Dongwoon-anatech-co
Analog-devices-inc
Synaptics-inc
D-systems-corp
Microchip-technology-inc
Immersion-corp
Ultraleap-ltd

Haptics Market Size to Grow by USD 15.83 billion | Increased Demand for In-car Infotainment Services to Drive Growth

/PRNewswire/ Haptics is a tactile feedback technology that reinvents the sense of touch by applying forces, vibrations, or motions to the user. Through this.

Japan
Bristol
City-of
United-kingdom
Tokyo
United-states
Texas
China
South-korea
America
Korea
Jesse-maida

Haptics Market Size to Surpass USD 15.84 Billion growth by 2025 at 15.96% CAGR

Haptics Market Size to Surpass USD 15.84 Billion growth by 2025 at 15.96% CAGR
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Texas
America
Jesse-maida
Dongwoon-anatech-co
Analog-devices-inc
Haptics-market-in-technology
Technavio-research
Immersion-corp
Microchip-technology-inc
Texas-instruments-inc

South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device

(Credit: Dongwoon Anatech) South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December. WHAT IT DOES The sugar monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent control technology in determining the glucose level present in a person’s saliva sample. The meter colour codes the result of the reading which is also recorded through a mobile app. WHY IT MATTERS Dongwoon conducted its first exploratory clinical trial in Nowon Eulji Medical Center – a university hospital in Seoul – involving 114 diabetic outpatients. The KOSDAQ-listed chipmaker is also planning to conduct D-SaLife’s clinical trials in the US, though it has not disclosed a date for it.

China
Seoul
Soult-ukpyolsi
South-korea
Australia
Japan
India
South-korean
Australian
Dongwoon-anatech
Nowon-eulji-medical-center
Drug-administration

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.